Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testosterone | 24 | 2014 | 211 | 2.740 |
Why?
|
| Muscle, Skeletal | 19 | 2014 | 316 | 2.060 |
Why?
|
| Muscle Fibers, Skeletal | 8 | 2014 | 70 | 1.610 |
Why?
|
| Oxidative Stress | 11 | 2019 | 1003 | 1.430 |
Why?
|
| Apoptosis | 9 | 2016 | 1568 | 1.230 |
Why?
|
| Cystine | 3 | 2013 | 14 | 1.040 |
Why?
|
| Nicotine | 6 | 2018 | 302 | 0.990 |
Why?
|
| Acetylcysteine | 3 | 2011 | 57 | 0.960 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 5 | 2013 | 84 | 0.810 |
Why?
|
| Myocytes, Cardiac | 2 | 2016 | 183 | 0.720 |
Why?
|
| Fatty Liver | 5 | 2019 | 77 | 0.710 |
Why?
|
| Sarcopenia | 2 | 2013 | 15 | 0.700 |
Why?
|
| Aging | 5 | 2013 | 783 | 0.680 |
Why?
|
| Satellite Cells, Skeletal Muscle | 3 | 2006 | 9 | 0.670 |
Why?
|
| Antioxidants | 3 | 2013 | 443 | 0.610 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2010 | 91 | 0.600 |
Why?
|
| Mice, Inbred C57BL | 13 | 2019 | 1869 | 0.590 |
Why?
|
| Mitochondria | 3 | 2014 | 523 | 0.580 |
Why?
|
| Signal Transduction | 8 | 2018 | 2157 | 0.550 |
Why?
|
| Receptors, Notch | 3 | 2014 | 38 | 0.450 |
Why?
|
| Parabiosis | 1 | 2014 | 2 | 0.430 |
Why?
|
| Muscle Development | 2 | 2014 | 51 | 0.430 |
Why?
|
| Selenomethionine | 2 | 2011 | 13 | 0.410 |
Why?
|
| Caspase 2 | 2 | 2014 | 7 | 0.390 |
Why?
|
| Prediabetic State | 1 | 2014 | 69 | 0.390 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 107 | 0.390 |
Why?
|
| Spermine | 2 | 2010 | 67 | 0.390 |
Why?
|
| Male | 35 | 2019 | 23409 | 0.380 |
Why?
|
| Glutathione | 2 | 2010 | 171 | 0.370 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 105 | 0.370 |
Why?
|
| Vitamin D | 1 | 2014 | 196 | 0.370 |
Why?
|
| Hypertrophy | 5 | 2014 | 34 | 0.370 |
Why?
|
| Minocycline | 1 | 2011 | 6 | 0.350 |
Why?
|
| Dietary Fats | 2 | 2011 | 117 | 0.350 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 64 | 0.340 |
Why?
|
| Myostatin | 4 | 2009 | 61 | 0.340 |
Why?
|
| Maternal Exposure | 1 | 2011 | 57 | 0.330 |
Why?
|
| Mice | 14 | 2019 | 6644 | 0.330 |
Why?
|
| Animals | 19 | 2019 | 16992 | 0.330 |
Why?
|
| Body Composition | 9 | 2011 | 159 | 0.300 |
Why?
|
| Down-Regulation | 1 | 2011 | 456 | 0.300 |
Why?
|
| Inflammation | 2 | 2014 | 758 | 0.300 |
Why?
|
| Muscular Diseases | 1 | 2009 | 22 | 0.290 |
Why?
|
| Cocaine | 1 | 2011 | 251 | 0.280 |
Why?
|
| AMP-Activated Protein Kinases | 4 | 2018 | 68 | 0.280 |
Why?
|
| Cardiotoxins | 1 | 2007 | 2 | 0.270 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 1596 | 0.270 |
Why?
|
| Receptors, Androgen | 2 | 2004 | 144 | 0.250 |
Why?
|
| Obesity | 2 | 2014 | 1151 | 0.250 |
Why?
|
| Immunohistochemistry | 5 | 2019 | 934 | 0.250 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2014 | 128 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2011 | 152 | 0.240 |
Why?
|
| Enzyme Activation | 4 | 2010 | 462 | 0.230 |
Why?
|
| Nitric Oxide | 1 | 2007 | 386 | 0.220 |
Why?
|
| Hepatocytes | 3 | 2014 | 80 | 0.210 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 830 | 0.200 |
Why?
|
| Organ Size | 3 | 2014 | 170 | 0.190 |
Why?
|
| Weight Loss | 5 | 2006 | 137 | 0.190 |
Why?
|
| Humans | 29 | 2019 | 43102 | 0.180 |
Why?
|
| Phosphorylation | 3 | 2016 | 986 | 0.170 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2011 | 76 | 0.160 |
Why?
|
| Double-Blind Method | 8 | 2005 | 317 | 0.160 |
Why?
|
| Aldehydes | 2 | 2010 | 70 | 0.150 |
Why?
|
| Cotinine | 1 | 2019 | 44 | 0.150 |
Why?
|
| HIV Infections | 7 | 2006 | 2586 | 0.140 |
Why?
|
| Adult | 19 | 2014 | 13872 | 0.140 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 67 | 0.140 |
Why?
|
| Menstrual Cycle | 1 | 1998 | 36 | 0.140 |
Why?
|
| Myogenin | 2 | 2009 | 6 | 0.140 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2009 | 47 | 0.130 |
Why?
|
| Triglycerides | 3 | 2014 | 147 | 0.130 |
Why?
|
| Models, Biological | 3 | 2016 | 712 | 0.130 |
Why?
|
| Benzamides | 1 | 2018 | 81 | 0.130 |
Why?
|
| Placebos | 3 | 2014 | 41 | 0.130 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 36 | 0.130 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 34 | 0.130 |
Why?
|
| Caspases | 1 | 2016 | 148 | 0.120 |
Why?
|
| Body Weight | 3 | 2014 | 429 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2006 | 1124 | 0.120 |
Why?
|
| Middle Aged | 14 | 2014 | 12222 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2014 | 81 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 3 | 2003 | 216 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2006 | 224 | 0.110 |
Why?
|
| C-Reactive Protein | 2 | 2014 | 167 | 0.110 |
Why?
|
| Cell Count | 2 | 2006 | 145 | 0.110 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2014 | 23 | 0.110 |
Why?
|
| Microscopy, Electron | 2 | 2006 | 210 | 0.110 |
Why?
|
| Gonadotropin-Releasing Hormone | 3 | 2003 | 39 | 0.110 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2014 | 12 | 0.100 |
Why?
|
| Lipolysis | 1 | 2014 | 20 | 0.100 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2014 | 41 | 0.100 |
Why?
|
| Pyrazines | 1 | 2014 | 32 | 0.100 |
Why?
|
| Adipose Tissue | 2 | 2014 | 182 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2019 | 883 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2014 | 165 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 160 | 0.100 |
Why?
|
| Hypogonadism | 2 | 2004 | 23 | 0.100 |
Why?
|
| Muscle Fibers, Fast-Twitch | 2 | 2003 | 7 | 0.100 |
Why?
|
| Mice, Knockout | 2 | 2019 | 1035 | 0.100 |
Why?
|
| Luteinizing Hormone | 6 | 2005 | 61 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2014 | 213 | 0.090 |
Why?
|
| HIV Wasting Syndrome | 2 | 2004 | 8 | 0.090 |
Why?
|
| Reference Values | 3 | 2004 | 211 | 0.090 |
Why?
|
| Treatment Outcome | 3 | 2013 | 1604 | 0.090 |
Why?
|
| Lipogenesis | 1 | 2011 | 19 | 0.090 |
Why?
|
| Imidazoles | 2 | 2009 | 142 | 0.090 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 32 | 0.090 |
Why?
|
| Pyridines | 2 | 2009 | 139 | 0.090 |
Why?
|
| Mice, Obese | 3 | 2018 | 42 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 234 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2010 | 37 | 0.080 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 138 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2014 | 925 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 138 | 0.080 |
Why?
|
| Enzyme Inhibitors | 2 | 2009 | 458 | 0.080 |
Why?
|
| Heart | 1 | 2011 | 184 | 0.080 |
Why?
|
| Sex Hormone-Binding Globulin | 4 | 2005 | 25 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2010 | 140 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2011 | 1766 | 0.070 |
Why?
|
| Glucose | 1 | 2010 | 244 | 0.070 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2008 | 15 | 0.070 |
Why?
|
| Caspase 9 | 1 | 2008 | 30 | 0.070 |
Why?
|
| Female | 8 | 2014 | 24698 | 0.070 |
Why?
|
| Risk Factors | 2 | 2014 | 3994 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2010 | 193 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2019 | 575 | 0.060 |
Why?
|
| Spermatozoa | 1 | 2008 | 214 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 196 | 0.060 |
Why?
|
| Smoking | 1 | 2014 | 1024 | 0.060 |
Why?
|
| Cell Death | 1 | 2007 | 278 | 0.060 |
Why?
|
| Insulin Resistance | 2 | 2006 | 201 | 0.060 |
Why?
|
| Body Fat Distribution | 1 | 2006 | 26 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2006 | 49 | 0.060 |
Why?
|
| Rats | 2 | 2011 | 3735 | 0.060 |
Why?
|
| Biopsy | 1 | 2006 | 177 | 0.060 |
Why?
|
| Pregnancy | 1 | 2011 | 1772 | 0.060 |
Why?
|
| Cell Division | 1 | 2006 | 311 | 0.060 |
Why?
|
| Sexual Behavior | 3 | 2005 | 638 | 0.060 |
Why?
|
| Leuprolide | 1 | 2004 | 8 | 0.060 |
Why?
|
| Postmenopause | 1 | 2005 | 141 | 0.060 |
Why?
|
| Androstenedione | 1 | 2004 | 19 | 0.060 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2004 | 35 | 0.060 |
Why?
|
| Aged | 7 | 2006 | 8214 | 0.060 |
Why?
|
| Adolescent | 7 | 2006 | 6081 | 0.050 |
Why?
|
| Androgens | 1 | 2004 | 106 | 0.050 |
Why?
|
| Pluripotent Stem Cells | 1 | 2003 | 31 | 0.050 |
Why?
|
| Biopsy, Needle | 2 | 2019 | 59 | 0.050 |
Why?
|
| Affect | 1 | 2005 | 180 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2003 | 19 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 46 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 652 | 0.050 |
Why?
|
| Oxymetholone | 1 | 2002 | 1 | 0.050 |
Why?
|
| Dihydrotestosterone | 2 | 1999 | 28 | 0.050 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2002 | 10 | 0.050 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2002 | 10 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2009 | 1455 | 0.050 |
Why?
|
| Anabolic Agents | 1 | 2002 | 20 | 0.050 |
Why?
|
| Cytokines | 1 | 2006 | 678 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2004 | 536 | 0.040 |
Why?
|
| Follicle Stimulating Hormone | 2 | 1998 | 43 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2003 | 383 | 0.040 |
Why?
|
| Cognition | 1 | 2005 | 473 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2003 | 611 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2004 | 1621 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 2676 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2001 | 131 | 0.040 |
Why?
|
| Bed Rest | 1 | 1999 | 3 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1271 | 0.040 |
Why?
|
| Muscular Atrophy | 1 | 1999 | 13 | 0.040 |
Why?
|
| Triiodothyronine | 1 | 1999 | 36 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1998 | 8 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2001 | 242 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 147 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 587 | 0.040 |
Why?
|
| Dialysis | 1 | 1998 | 7 | 0.040 |
Why?
|
| Radioimmunoassay | 1 | 1998 | 70 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 1999 | 1285 | 0.030 |
Why?
|
| Energy Intake | 2 | 2011 | 164 | 0.030 |
Why?
|
| Exercise | 2 | 2001 | 692 | 0.030 |
Why?
|
| Administration, Topical | 2 | 2006 | 39 | 0.030 |
Why?
|
| Administration, Cutaneous | 3 | 2001 | 48 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 1998 | 1081 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2012 | 27 | 0.020 |
Why?
|
| HIV-1 | 1 | 1998 | 755 | 0.020 |
Why?
|
| Insulin | 2 | 2006 | 258 | 0.020 |
Why?
|
| Animal Feed | 1 | 2012 | 53 | 0.020 |
Why?
|
| Abdominal Fat | 1 | 2011 | 21 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2012 | 108 | 0.020 |
Why?
|
| Hormones | 2 | 2001 | 55 | 0.020 |
Why?
|
| Absorptiometry, Photon | 2 | 2002 | 76 | 0.020 |
Why?
|
| Adiposity | 1 | 2011 | 157 | 0.020 |
Why?
|
| Blood Glucose | 2 | 2002 | 389 | 0.020 |
Why?
|
| Liver | 1 | 2012 | 511 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2008 | 3 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 12 | 0.020 |
Why?
|
| Fever | 1 | 2008 | 62 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 137 | 0.020 |
Why?
|
| Testis | 1 | 2008 | 207 | 0.020 |
Why?
|
| Placebo Effect | 1 | 2006 | 14 | 0.020 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2005 | 3 | 0.010 |
Why?
|
| Gels | 1 | 2005 | 45 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2005 | 95 | 0.010 |
Why?
|
| Thrombosis | 1 | 2006 | 81 | 0.010 |
Why?
|
| Menstruation | 1 | 2004 | 11 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2004 | 64 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2004 | 67 | 0.010 |
Why?
|
| Exercise Test | 1 | 2004 | 74 | 0.010 |
Why?
|
| California | 1 | 2006 | 548 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2003 | 51 | 0.010 |
Why?
|
| Comorbidity | 1 | 2006 | 737 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 719 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 388 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2004 | 233 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2003 | 141 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 695 | 0.010 |
Why?
|
| Stem Cells | 1 | 2003 | 152 | 0.010 |
Why?
|
| Fasting | 1 | 2002 | 56 | 0.010 |
Why?
|
| Apolipoproteins C | 1 | 2002 | 3 | 0.010 |
Why?
|
| Apolipoprotein C-III | 1 | 2002 | 7 | 0.010 |
Why?
|
| Nutrition Assessment | 1 | 2002 | 80 | 0.010 |
Why?
|
| Apolipoproteins B | 1 | 2002 | 18 | 0.010 |
Why?
|
| Body Water | 1 | 2001 | 26 | 0.010 |
Why?
|
| Androgen Antagonists | 1 | 2001 | 29 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 518 | 0.010 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2001 | 36 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2002 | 99 | 0.010 |
Why?
|
| Half-Life | 1 | 2001 | 63 | 0.010 |
Why?
|
| Age Factors | 1 | 2004 | 1154 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2004 | 638 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2003 | 665 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2002 | 119 | 0.010 |
Why?
|
| Lipids | 1 | 2002 | 256 | 0.010 |
Why?
|
| Thigh | 1 | 2000 | 12 | 0.010 |
Why?
|
| Cholesterol | 1 | 2002 | 232 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 2000 | 25 | 0.010 |
Why?
|
| Head-Down Tilt | 1 | 1999 | 4 | 0.010 |
Why?
|
| Biological Availability | 1 | 2000 | 116 | 0.010 |
Why?
|
| Estradiol | 1 | 2002 | 268 | 0.010 |
Why?
|
| Quality of Life | 1 | 2004 | 616 | 0.010 |
Why?
|
| Thyroxine | 1 | 1999 | 22 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1999 | 24 | 0.010 |
Why?
|
| Weightlessness Simulation | 1 | 1999 | 26 | 0.010 |
Why?
|
| Sex Factors | 1 | 2003 | 1028 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2003 | 1546 | 0.010 |
Why?
|
| Introns | 1 | 1998 | 79 | 0.010 |
Why?
|
| CHO Cells | 1 | 1998 | 123 | 0.010 |
Why?
|
| Exons | 1 | 1998 | 92 | 0.010 |
Why?
|
| Cricetinae | 1 | 1998 | 241 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1998 | 199 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 314 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2000 | 236 | 0.010 |
Why?
|
| Cattle | 1 | 1998 | 498 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 515 | 0.010 |
Why?
|
| Base Sequence | 1 | 1998 | 983 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 1542 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 2853 | 0.010 |
Why?
|
| Emotions | 1 | 1998 | 254 | 0.010 |
Why?
|
| Child | 1 | 2003 | 3443 | 0.010 |
Why?
|